A Cohort Study of Operationally Tolerant Allograft Recipients

(

ALLTOL

)

ITN Protocol #:

ITN063ST

Branded Name:

ALLTOL

ClinicalTrials.Gov ID:

NCT02743793

Treatment Protocol #:

Therapeutic Area:

Transplantation

Current Status:

Complete

ITN Website Clinical Trial Recruiting Site Document Portal Location Study on ITN TrialShare

Summary:

A Prospective Cohort Study of Operationally Tolerant Allograft Recipients

Clinical Operations Associate Director

Clinical Operations Manager

ITN Biologist

ITN Biostat

NIAID Project Manager

Rho Scientist

PPD Lead Monitor

Study Personnel:

Protocol Chair

Sindhu Chandran, MD schandran@immunetolerance.org

Work:

415-610-4284

Protocol Chair

Michele DesMarais mdesmarais@immunetolerance.org

Work:

415-420-4250

Protocol Chair

Geo Gaile ggaile@immunetolerance.org

Work:

415-854-7485

Protocol Chair

Cynthia Breeden, MPH cbreeden@immunetolerance.org

Work:

404-379-5811

Protocol Chair

Sai Kanaparthi skanaparthi@immunetolerance.org

Work:

(240)235-6101

Protocol Chair

Allison Priore allison.girouard@nih.gov

Work:

240-627-3550

Protocol Chair

Karen Kesler karen.kesler@rhoworld.com

Work:

919-595-6244

Protocol Chair

Brian Long brian.long@ppdi.com

Work:

303-733-0930